• Aucun résultat trouvé

Managing opioids

N/A
N/A
Protected

Academic year: 2022

Partager "Managing opioids"

Copied!
1
0
0

Texte intégral

(1)

É D I T O R I A L

This article is also in English on page 000. Références à la page 000.

COLLEGE

}

COLLÈGE P R E S I D E N T ' S M E S S A G E

Managing opioids

O

ne night, while I was working in the emergency department, I sutured a young man’s laceration.

While doing so, the patient admitted to me that he had a narcotic addiction. I offered him assistance and then asked him, “You take such large doses of opioids every day. Isn’t it expensive?”

He replied, “I wouldn’t be able to afford it on the black market, but my grandfather has a prescription from his physician and I take some of his pills.”

I understood then that one of my colleagues was his

“provider.”

When I frst began practising, there were numerous conferences on pain management and several present- ers would tell us that physicians undertreated pain. At the time, we rarely heard about addiction and abuse in the media or in our communities. But today it is a pub- lic health crisis. Although resellers have many supply sources, we know that the well-intentioned prescriptions of physicians and dentists contribute to the problem.

I recently received a request for a hydromorphone prescription renewal from one of my patients. I had been his family physician for a few years and I had never pre- scribed him any opioids. He had had problems with sub- stance abuse in the past, but he had not used for years.

While he was visiting the emergency department for abdominal pain, he received a presumptive diagnosis of lymphoma after multiple adenopathies were discovered on a scan. I was concerned about the number of pills the patient was given relative to the type of illness he had. I reexamined him at my offce. He was suffering so much that I requested he be hospitalized so that his diagnosis could be reevaluated and his pain quickly controlled.

The patient was hospitalized only very briefy before I saw him again at my offce. He was suffering so much that he told me he would not be able to return home. He explained to me that the physician at the hospital did not want to give him too many opioids because of his history of substance abuse. I could well understand my colleague’s hesitation but, knowing my patient, I sus- pected something unusual was happening. I had him

Guillaume Charbonneau MD CCMF FCMF

hospitalized again and he passed away a few weeks later from a rare form of sarcoma.

When managing opioids, the balance between pain relief and risk of abuse, addiction, and death can be very diffcult to achieve.

The College of Family Physicians of Canada is a part of the Pan-Canadian Collaborative on Education for Improved Opioid Prescribing. It has collaborated on promoting the 2017 Canadian Guideline for Opioids for Chronic Non-Cancer Pain,1 the Opioid Manager tool,2 and other resources on the subject. The College has also produced a Self-Learning special issue on opioids that is available to all members for free and is working on other initiatives as well.

Nevertheless, regardless of what organizations are doing, it is truly our work on the ground that will make a difference. As family physicians, we must give our- selves the mandate to reduce the overall number of opi- oids we are putting into circulation while assisting our patients in effectively managing their pain.

I am confdent in our ability to overcome this chal- lenge. A recent Health Quality Ontario report has noted a decrease in opioid prescriptions by family physicians.3 This decrease is not suffcient, but it is a good start.

There is no magic formula and so our duty is to use 2 of family medicine’s greatest strengths to address this challenge: judgment centred on our comprehen- sive vision of patient health, and continuity of care for actively dealing with opioid management.

We know our science, the doctor-patient relationship is at the heart of our specialty, and we have our commu- nity’s well-being at heart. The only thing left to do is to apply the art of medicine.

References

1. Busse J, editor. The 2017 Canadian guideline for opioids for chronic non-cancer pain. Hamilton, ON: National Pain Centre, McMaster University; 2017. Available from:

http://nationalpaincentre.mcmaster.ca/documents/Opioid%20GL%20for%20 CMAJ_01may2017.pdf. Accessed 2018 Feb 13.

2. Opioid Manager [website]. Toronto, ON: Centre for Effective Practice; 2017. Available from: https://thewellhealth.ca/pain. Accessed 2018 Feb 13.

3. Grant K. Ontario sees drop in opioid prescriptions: report. The Globe and Mail 2018 Jan 25. Available from: www.theglobeandmail.com/news/national/ontario-sees- drop-in-opioid-prescriptions-report/article37727505. Accessed 2018 Feb 12.

Cet article se trouve aussi en français à la page 238.

Vol 64: MARCH | MARS 2018 |Canadian Family Physician | Le Médecin de famille canadien

237

Références

Documents relatifs

Tools for Practice articles in Canadian Family Physician (CFP) are adapted from articles published on the Alberta College of Family Physicians (ACFP) website, summarizing medical

For patients at higher risk of misuse, the Canadian guideline recommends prescribing opioids only if patients have “well-defined somatic or neuro- pathic pain conditions.”

The Canadian Guideline for Safe and Effective Use of Opioids for Chronic Non-Cancer Pain has been developed by consensus collaboration among physicians treating pain

Objective To provide family physicians with a practical clinical summary of the Canadian Guideline for Safe and Effective Use of Opioids for Chronic Non-Cancer

These include baseline risk factors (eg, psychiatric disorders, strong per- sonal or family history of addiction); an opioid dose that is far in excess of what would normally

Such treatment is in line with the recommendations of the American Pain Society and the American Academy of Pain Medicine published in 2009, which stipulated

Weak or partial opioid agonists: Considerations in the elderly with chronic noncancer pain.. DRuG INITIaL LOW

Primary care physicians face multiple barriers to successfully treating chronic pain with opioids, many of which are made more difficult when a newly licensed